| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000005617 |
| Receipt No. | R000006629 |
| Official scientific title of the study | Biological assessment for brain tumors in 5-ALA-induced fluorescence-guided surgery |
| Date of disclosure of the study information | 2011/05/20 |
| Last modified on | 2018/11/22 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Biological assessment for brain tumors in 5-ALA-induced fluorescence-guided surgery | |
| Title of the study (Brief title) | Fluorescence-guided surgery for brain tumors | |
| Region |
|
|
| Condition | ||
| Condition | Brain tumors | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This report analyzed relationships among histology,
radiological findings, and 5-ALA-induced fluorescence, using surgical specimens obtained with navigation-guided stereotactic biopsy. The present study aimed to reveal the tumor characteristics relating with 5-ALA-induced fluorescence, in order to refine glioma resection using these techniques. |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Histological findings of surgical specimens and 5-ALA induced fluorescence |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oral administration of 5-ALA | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who meet all of the requirements described below are includesd.
1. Patients who are hospitalized in order to undergo surgery. 2. Patients whose preoperative diagnosis is glioma, meningioma or metastatic brain tumor. 3. Patients who provide a written informed consent. |
|||
| Key exclusion criteria | Patients who meet any of the conditions described below are excluded.
1. Patients with hypersensitivity to 5-ALA or porphyrins. 2. In case of known or suspected pregnancy, or women who are breast-feeding. 3.In case of known or suspected acute or chronic types of porphyria. 4. In case of renal insufficiency (serum creatinine is more than 2.0mg/dl) 5. In case of hepatic insufficiency (serum gamma glutamyl transpeptidase >100IU/l, ptotronbin time <60% or total bilirubin >3mg/dl) 6. In case of other conditions considered as undesirable for entry in this clinical trial. |
|||
| Target sample size | 75 | |||
| Research contact person | |
| Name of lead principal investigator | Naoya Hashimoto |
| Organization | Osaka University Hospital |
| Division name | Department of Neurosurgery |
| Address | 2-15, Yamadaoka, Suita, Osaka 565-0871, Japan |
| TEL | 0668793652 |
| hashimotonaoya@me.com | |
| Public contact | |
| Name of contact person | Hideyuki Arita |
| Organization | Osaka University Hospital |
| Division name | Department of Neurosurgery |
| Address | 2-15, Yamadaoka, Suita, Osaka 565-0871, Japan |
| TEL | 06-6879-5111 |
| Homepage URL | |
| h-arita@nsurg.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Department of Neurosrugery, Osaka University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪大学医学部付属病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000006629 |